|
Related Topics
|
Home: Testing of Chemicals >
Presentations from the OECD Industry Event, Multilateral Symposium between Monitoring Authorities, Regulatory Authorities and Test Facilities on the Implementation of the OECD Principles of GLP
Presentations from the OECD Industry Event, Multilateral Symposium between Monitoring Authorities, Regulatory Authorities and Test Facilities on the Implementation of the OECD Principles of GLP
|
- Presentation 1 - Opening of the Event
- Presentation 2 - Current State of implementation by Members and Non-Members of the OECD Council Decisions Related to MAD
Presentation 3 - Quest for Harmonisation: Differences and Similarities in National Programmes for GLP Monitoring
- Presentation 4 - Future Issues including Broadening the Scope of the GLP Princilpes
- Presentation 5 - OECD Principles of GLP: What is Working and What Needs Work
- Presentation 6 - Implementation of OECD Principles in Test Facilities Complying with a Quality System Accredited to ISO/IEC 17025
- Presentation 7a - Critical Aspects in Implementing the OECD Monograph 14 'The Application of the Principles of GLP to In-vitro Studies'
- Presentation 7b - Critical Aspects in Implementing the OECD Monograph 14 'The Application of the Principles of GLP to In-vitro Studies'
- Presentation 8 - Relationship between Receiving Authorities and Monitoring Authorities: The EMEA Experience
- Presentation 9 - Collaboration between Monitoring Authorities, Regulatory Authorities and Test Facilities on GLP Principles
- Presentation 10 - National GLP Programmes and Implication of Pharmaceuticals, Pesticides and Other Chemicals Regulatory Authorities in Japan
- Presentation 11 - GLP 30 Years on: Challenges for Industry
- Presentation 12 - Implementation of the OECD GLP Principles at Test Facilities in Japan
- Presentation 13 - Risk based Assessment Applied to QA GLP Audits
- Presentation 14 - Critical Aspects Regarding the Application of GLP Principles to New Compounds such as Biotechnology Products
- Presentation 15a - GLP: Key Issues from the Point of View of a Test Facility
- Presentation 15b - GLP: Key Issues from the Point of View of a Test Facility
- Presentation 16 - Differences in the interpretation of the GLP Requirements by OECD Monitoring Authorities: The Point of View of the Pharmaceutical Industry
- Presentation 17 - OECD and US GLP Applications
- Presentation 18 - Responsibilities of Test Facility Management and Sponsor
- Presentation 19 - Developments in GLP Consultation and Training 1980-2020
|
Top of page
|
|
